Evidence map›Paper›PMID 29143673›Full record

ArticleBMC infectious diseases2017

The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing.

Joseph D Tucker, Kathrine Meyers, John Best, Karyn Kaplan, Razia Pendse, Kevin A Fenton, Isabelle Andrieux-Meyer, Carmen Figueroa, Pedro Goicochea, Charles Gore and 10 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Trial
  5. Aspects that facilitate access to care for viral hepatitis: An evaluative research.Sao Paulo medical journal = Revista paulista de medicina · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 16 institutions in 8 countries.

Joseph D TuckerUniversity of North Carolina Chapel Hill Project-China, Number 2 Lujing Road, Guangzhou, 510095, China. jdtucker@med.unc.edu.
Kathrine MeyersSESH Global, Number 2 Lujing Road, Guangzhou, 510095, China.
John BestSESH Global, Number 2 Lujing Road, Guangzhou, 510095, China.
Karyn KaplanAsia Catalyst, 1109, 1270 Broadway, New York, NY, 1001, USA.
Razia PendseWHO Regional Office for South East Asia, World Health House, Indraprastha Estate, Mahatma Gandhi Marg, New Delhi, Delhi, 110002, India.
Kevin A FentonSESH Global, Number 2 Lujing Road, Guangzhou, 510095, China.
Isabelle Andrieux-MeyerMédecins Sans Frontières, Rue de Lausanne 78, 1202, Genève, Switzerland.
Carmen FigueroaWorld Health Organization HIV Department, 20 Avenue Appia, CH-1211, Geneva 27, Switzerland.
Pedro GoicocheaForum for Collaborative HIV Research and the University of California Berkeley School of Public Health, 1608 Rhode Island Avenue NW, Suite 212, Washington, DC, 20036, USA.
Charles GoreWorld Hepatitis Alliance, 1 Baden Place, London, SE1 1YW, UK.
Azumi IshizakiHepatitis C Trust, 27 Crosby Road, London, SE1 3YD, UK.
Giten KhwairakpamTREAT Asia, Exchange Tower, 388 Sukhumvit Road, Suite 2104, Klongtoey, Bangkok, 10110, Thailand.
Veronica MillerForum for Collaborative HIV Research and the University of California Berkeley School of Public Health, 1608 Rhode Island Avenue NW, Suite 212, Washington, DC, 20036, USA.
Antons MozalevskisWHO Regional Office for Europe, UN City, Marmorvej 51, DK-2100, Copenhagen, Denmark.
Michael NinburgHepatitis Education Project, 1621 S. Jackson Street, 2t 201, Seattle, WA, 98144, USA.
Ponsiano OcamaDepartment of Medicine, Makere College of Health Sciences, PO Box 7072, Kampala, Uganda.
Rosanna PeelingLondon School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Nick WalshThe WHO Regional Office for the Western Pacific, P.O. Box 2932, 1000, Manila, Philippines.
Massimo G ColomboIRCCS Humanitas Hospital, Rozzano, Italy.
Philippa EasterbrookWorld Health Organization HIV Department, 20 Avenue Appia, CH-1211, Geneva 27, Switzerland.
The Hepatitis C Trust · GBUniversity of California, Berkeley · USWorld Health Organization · CHAaron Diamond AIDS Research Center · USCommunity Catalyst · USHepatitis B Foundation · USHospital of the University of Pennsylvania · USIRCCS Humanitas Research Hospital · ITLondon Borough of Southwark · GBLondon School of Hygiene & Tropical Medicine · GBMakerere University · UGMédecins Sans Frontières · CHUniversity of North Carolina at Chapel Hill · USWorld Health Organization Regional Office for Europe · DKWorld Health Organization Regional Office for South-East Asia · INWorld Health Organization Regional Office for the Western Pacific · PH

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundInnovation contests are a novel approach to elicit good ideas and innovative practices in various areas of public health. There remains limited published literature on approaches to deliver hepatitis testing. The purpose of this innovation contest was to identify examples of different hepatitis B and C approaches to support countries in their scale-up of hepatitis testing and to supplement development of formal recommendations on service delivery in the 2017 World Health Organization hepatitis B and C testing guidelines.

methodsThis contest involved four steps: 1) establishment of a multisectoral steering committee to coordinate a call for contest entries; 2) dissemination of the call for entries through diverse media (Facebook, Twitter, YouTube, email listservs, academic journals); 3) independent ranking of submissions by a panel of judges according to pre-specified criteria (clarity of testing model, innovation, effectiveness, next steps) using a 1-10 scale; 4) recognition of highly ranked entries through presentation at international conferences, commendation certificate, and inclusion as a case study in the WHO 2017 testing guidelines.

resultsThe innovation contest received 64 entries from 27 countries and took a total of 4 months to complete. Sixteen entries were directly included in the WHO testing guidelines. The entries covered testing in different populations, including primary care patients (n = 5), people who inject drugs (PWID) (n = 4), pregnant women (n = 4), general populations (n = 4), high-risk groups (n = 3), relatives of people living with hepatitis B and C (n = 2), migrants (n = 2), incarcerated individuals (n = 2), workers (n = 2), and emergency department patients (n = 2). A variety of different testing delivery approaches were employed, including integrated HIV-hepatitis testing (n = 12); integrated testing with harm reduction and addiction services (n = 9); use of electronic medical records to support targeted testing (n = 8); decentralization (n = 8); and task shifting (n = 7).

conclusionThe global innovation contest identified a range of local hepatitis testing approaches that can be used to inform the development of testing strategies in different settings and populations. Further implementation and evaluation of different testing approaches is needed.

Indexed as

Guidelines as TopicHepatitis BHepatitis CHumansMass ScreeningPrimary Health CarePublic HealthWorld Health Organization

Identifiers

PMID29143673
PMCPMC5688427
OpenAlexW2766920351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.